Pharmaceutical News

RSS

Taking painkillers before race leads to unrecognised problems

Many competitors try to prevent pain interfering with their performance by taking painkillers that are readily available in pharmacies and supermarkets, say the authors.

20 Apr 2013

Drug that targets phosphate does not improve CVD measures in patients with mild kidney disease

High phosphate levels in the blood carry increased heart-related risks, but taking a drug that targets phosphate does not improve cardiovascular measures in patients with mild kidney disease, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN).

19 Apr 2013

Long winter months impact tamoxifen treatment for breast cancer

For women diagnosed with a form of breast cancer known as estrogen receptor positive (ER+) breast cancer, tamoxifen is an essential drug used in the treatment and prevention of recurring breast cancer.

19 Apr 2013

Arthritis drug reduces dry eye disease

Dry eye disease (DED) is a common condition that causes discomfort, visual disturbance and potentially damaging ocular surface inflammation that greatly impacts a person's quality of life.

19 Apr 2013

BIIR researchers report results of comparative study of molecular immune responses to influenza and pneumococcal vaccines

In a manuscript published today in Immunity, scientists at the Baylor Institute for Immunology Research (BIIR) and the Benaroya Research Institute at Virginia Mason report the results of a comparative study of the molecular immune responses to influenza and pneumococcal vaccines.

19 Apr 2013

Combination therapies may advance treatment for anaplastic thyroid cancer

A combination of therapies may prove to be a promising advance for the treatment of anaplastic thyroid cancer based on results of a phase I clinical trial, say researchers at Mayo Clinic in Florida.

19 Apr 2013

Neura Therapeutik plans to speed up development of abuse-deterrent, generic extended-release opioids

Neura Therapeutik announced today that they will be accelerating the development of their abuse-deterrent brand and generic extended-release opioids.

19 Apr 2013

Indian drug supplier cuts price of 5-in-1 childhood vaccine for GAVI Alliance; Groups highlight World Immunization Week

"The cost of immunizing children in developing countries with a five-in-one vaccine is set to fall after a deal by an Indian supplier to slash the price it charges the GAVI global vaccines group," Reuters reports.

19 Apr 2013

Blog examines implications of synthetic artemisinin production for global health

"This week, PATH and our partners celebrated the official launch of the production line for a new synthetic version of artemisinin, the key ingredient for the gold-standard malaria treatment -- one that plays a major role in protecting the lives of children and adults worldwide," PATH President and CEO Steve Davis writes in the Bill & Melinda Gates Foundation's "Impatient Optimists" blog.

19 Apr 2013

Global experts highlight strategies to immunize more children

In advance of World Immunization Week, global experts are highlighting strategies to further advance progress on the Global Vaccine Action Plan that was endorsed by the World Health Assembly, 2012.

19 Apr 2013

Ribavirin, interferon-alpha 2b inhibit virus replication in cell culture, NIH study finds

National Institutes of Health scientists studying an emerging coronavirus have found that a combination of two licensed antiviral drugs, ribavirin and interferon-alpha 2b, can stop the virus from replicating in laboratory-grown cells.

19 Apr 2013

Study finds dietary supplements accounted for more than half the Class 1 drugs recalled by FDA

Dietary supplements accounted for more than half the Class 1 drugs recalled by the U.S. Food and Drug Administration from 2004-12, meaning they contained substances that could cause serious health problems or even death, a new study from St. Michael's Hospital has found.

19 Apr 2013

Antibiotic resistance: A growing problem in hospital and outpatient settings

A new study concludes that problems with antibiotic resistance faced by outpatients may be as bad as those in hospitalized patients, and that more studies of outpatients are needed - both to protect their health and to avoid inappropriate or unnecessary drug use.

19 Apr 2013

First Edition: April 18, 2013

Today's headlines include reports from Capitol Hill about one Democratic senator's poor reviews of the Obama administration's progress in implementing the health law.

18 Apr 2013

New review of medications to prevent migraines appears in Journal of General Internal Medicine

Migraine headaches are a major cause of ill health and a reduced quality of life. Some individuals suffer from a frequent and severe migraine problem which means that they require regular medication to try and prevent them.

18 Apr 2013

FDA's PADAC supports approval of BREO ELLIPTA as once-daily inhaled treatment for COPD

GlaxoSmithKline plc and Theravance, Inc. today announced that the Pulmonary-Allergy Drugs Advisory Committee to the US Food and Drug Administration voted that the efficacy and safety data provide substantial evidence to support approval of BREO ELLIPTA as a once-daily inhaled treatment for the long-term, maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (9 for, 4 against) and also for the reduction of COPD exacerbations in patients with a history of exacerbations (9 for, 4 against).

18 Apr 2013

Santaris Pharma, Bristol-Myers Squibb partner to develop novel medicines using LNA Drug Platform

Santaris Pharma A/S, a privately held biopharmaceutical company focused on developing medicines targeted to disease-related mRNAs and microRNAs, today announced a worldwide strategic alliance with Bristol-Myers Squibb to discover and develop novel medicines using Santaris Pharma's proprietary Locked Nucleic Acid Drug Platform.

18 Apr 2013

Amgen agrees to $25M settlement after kickback allegations

The biotech drug maker was accused of paying kickbacks to increase sales of its anemia drug Aranesp.

18 Apr 2013

FDA authorizes SK Biopharmaceuticals' IND application for SKL15508 to treat CIAS

The Korea-based international pharmaceutical company, SK Biopharmaceuticals, announced today the U.S. Food and Drug Administration has authorized the Investigational New Drug application for SKL15508 to treat cognitive impairment associated with schizophrenia.

18 Apr 2013

Study: Half of Tamiflu prescriptions during 2009-10 influenza pandemic went unused in England

A new study concludes that approximately half of the prescriptions of Tamiflu during the 2009-10 influenza pandemic went unused in England.

18 Apr 2013

Pharmaceutical News

Taking painkillers before race leads to unrecognised problems

Drug that targets phosphate does not improve CVD measures in patients with mild kidney disease

Long winter months impact tamoxifen treatment for breast cancer

Arthritis drug reduces dry eye disease

BIIR researchers report results of comparative study of molecular immune responses to influenza and pneumococcal vaccines

Combination therapies may advance treatment for anaplastic thyroid cancer

Neura Therapeutik plans to speed up development of abuse-deterrent, generic extended-release opioids

Indian drug supplier cuts price of 5-in-1 childhood vaccine for GAVI Alliance; Groups highlight World Immunization Week

Blog examines implications of synthetic artemisinin production for global health

Global experts highlight strategies to immunize more children

Ribavirin, interferon-alpha 2b inhibit virus replication in cell culture, NIH study finds

Study finds dietary supplements accounted for more than half the Class 1 drugs recalled by FDA

Antibiotic resistance: A growing problem in hospital and outpatient settings

First Edition: April 18, 2013

New review of medications to prevent migraines appears in Journal of General Internal Medicine

FDA's PADAC supports approval of BREO ELLIPTA as once-daily inhaled treatment for COPD

Santaris Pharma, Bristol-Myers Squibb partner to develop novel medicines using LNA Drug Platform

Amgen agrees to $25M settlement after kickback allegations

FDA authorizes SK Biopharmaceuticals' IND application for SKL15508 to treat CIAS

Study: Half of Tamiflu prescriptions during 2009-10 influenza pandemic went unused in England

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News